Back to Rankings

ZTS

ZoetisD
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
Current thesis
Composite grade D from latest DB weights. Momentum 6.5 / Value 66.7
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.1.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
6
Value
67
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $108.64
Why
Momentum6 · Δ7d +5.2
Value67 · Δ7d -0.1
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
6
40% active weight
Current posture
7d trendFlat
Δ7d
+5.2
Δ21d
+5.9
Value
67
60% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.3
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade D. Momentum 6.5 / Value 66.7

Fundamentals (TTM)
As of 2026-07-20
Market Cap
$31.95B
Beta
0.96
Shares Out
419.23M
P/E (TTM)
21.8
P/S (TTM)
6.07
P/FCF (TTM)
41.40
Rev YoY
+2.9%
EPS YoY
+5.9%
Gross Margin
+70.4%
Op Margin
+35.4%
Net Debt
$6.99B
Current Ratio
3.15
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology